CRSP News and Press, CRISPR Therapeutics AG From 02/13/26

2026-02-13 09:35:07 ET More on The Health Care Select Sector SPDR® Fund ETF Big Pharma's Earnings Week: Strong Performance, Obesity Wars, LOE Management And More CMS Rates Proposal Shatters Health Insurance Stocks: What Investors Must Know (& Do) Insurers Br...

2026-02-12 22:37:04 ET This article is part of a series that provides an ongoing analysis of the changes made to ARK Invest’ 13F portfolio on a quarterly basis. It is based on their regulatory 13F Form filed on 02/11/2026.... Read the full article on Seeking Alpha ...

2026-02-12 16:40:41 ET More on CRISPR Therapeutics Crispr Therapeutics: Patience And Opportunity Through Volatility 44th Annual J.P. Morgan Healthcare Conference CRISPR Therapeutics AG (CRSP) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript ...

ZUG, Switzerland and BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the fourth quarter and full year ended December 31, 2025. “As we close out the fourth quarter, CRISPR Therapeutics continues to make steady pro...

Klaviyo Inc. Series A (KVYO) is expected to report $0.04 for Q4 2025 Diodes Incorporated (DIOD) is expected to report $0.26 for Q4 2025 CRISPR Therapeutics AG (CRSP) is expected to report $-1.15 for Q4 2025 Brighthouse Financial Inc. (BHF) is expected to report $5.19 for Q4 2025 B...

2026-02-07 12:03:45 ET More on Markets Micron: This Week's Dip Is A Gift Steven Cress' Top 10 AI Stocks (Recap & Update) GameStop May Not Be The Next Berkshire, But Exciting Times Are Ahead Tech Voices: Huang on AI CapEx, Goldman-Anthropic, China CPU dela...

2026-02-02 07:30:32 ET Cathie Wood's Ark Investment rotated money into high-conviction innovation themes, including AI, genomics, blockchain, and autonomous systems, while trimming exposure to mature biotech and established growth stocks.... Read the full article on Seeking Alpha ...

2026-01-29 12:48:00 ET Artificial intelligence (AI) is slowly changing and reshaping industries, from banking to telecom. The technology will likely make many jobs obsolete. Some of the corporations leading this revolution are already seeing massive financial benefits and outstanding stock ...

2026-01-28 08:05:23 ET Cutting DNA, Cutting Edge: Companies Using CRISPR and Other Gene Editing Technologies to Rewrite the Future of Industry and Medicine DENVER, Colo – CRISPR gene-editing, and related genome engineering technologies, are reshaping industries from medicine ...

2026-01-14 11:30:08 ET CRISPR Therapeutics (CRSP) continues to be one of the most puzzling stocks out there. Over the past year, the stock has swung wildly from a low of $31 to a high just north of $78, which is certainly much more volatile than the value of the underlying business. Dur...